Get the Stockscreener App
0.85
0.71%
0.006
Pre-market:
.86
0.01
+1.18%
AEON Biopharma Inc. stock is traded at $0.85, with a volume of 99,694.
It is up +0.71% in the last 24 hours and up +5.12% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$0.844
Open:
$0.84
24h Volume:
99,694
Relative Volume:
0.54
Market Cap:
$9.90M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-9.57%
1M Performance:
+5.12%
6M Performance:
+96.30%
1Y Performance:
-98.71%
1-Day Range:
$0.8301
$0.8648
1-Week Range:
$0.83
$0.9585
52-Week Range:
$0.375
$66.23
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.85 | 9.83M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-23 | Initiated | H.C. Wainwright | Buy |
AEON Biopharma Inc. Stock (AEON) Latest News
How forex fluctuations impact AEON Biopharma Inc. Class stockPortfolio Gains Summary & Technical Pattern Alert System - newser.com
Will AEON Biopharma Inc. price bounce be sustainableJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
How AEON Biopharma Inc. Class stock valuation compares with sector2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
How AEON Biopharma Inc. Class stock benefits from digital adoptionJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - newser.com
Is AEON Biopharma Inc a good long term investmentDebt-to-Equity Ratio Analysis & High Return Trading Portfolio - earlytimes.in
Detecting price anomalies in AEON Biopharma Inc. with AIJuly 2025 Technicals & Daily Stock Momentum Reports - newser.com
How AEON Biopharma Inc. stock performs during Fed tightening cyclesMarket Volume Report & Capital Efficient Trade Techniques - newser.com
Is AEON Biopharma Inc. stock attractive for ETFsPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - newser.com
Will AEON Biopharma Inc. outperform the marketJuly 2025 Action & Stepwise Trade Signal Implementation - newser.com
What Fibonacci levels say about AEON Biopharma Inc. reboundJuly 2025 Analyst Calls & AI Based Buy and Sell Signals - newser.com
How AEON Biopharma Inc. Class stock responds to job market shifts2025 Year in Review & Risk Managed Investment Entry Signals - newser.com
AEON Biopharma, Inc. (NASDAQ:AEON) Sees Significant Growth in Short Interest - Defense World
How AEON Biopharma Inc. stock trades before earnings2025 Short Interest & Accurate Entry and Exit Point Alerts - Fundação Cultural do Pará
Aug Shorts: Can AEON Biopharma Inc. stock attract ESG capital inflowsJuly 2025 Sector Moves & Precise Trade Entry Recommendations - fcp.pa.gov.br
AEON Biopharma Inc. Stock (AEON) Financials Data
There is no financial data for AEON Biopharma Inc. (AEON). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Cap:
|
Volume (24h):